Abstract
Because of the lack of significant disease-modifying drugs for neurodegenerative disorders, a pressing need for new chemical entities endowed with IMAO-B still exists. Within this framework, and for the first time, a study was performed to compare coumarin- and chomone-3-phenylcarboxamide scaffolds. Compounds 10a and 10b were the most potent, selective, and reversible noncompetitive IMAO-B. The benzopyrone sp2 oxygen atom was found to be position independent and a productive contributor for the ligand-enzyme complex stability.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alanine / analogs & derivatives
-
Alanine / pharmacology
-
Benzylamines / pharmacology
-
Chromones / chemical synthesis
-
Chromones / chemistry
-
Chromones / pharmacology*
-
Clorgyline / pharmacology
-
Coumarins / chemical synthesis
-
Coumarins / chemistry
-
Coumarins / pharmacology*
-
Humans
-
Indans / pharmacology
-
Kinetics
-
Ligands
-
Molecular Docking Simulation
-
Monoamine Oxidase / chemistry
-
Monoamine Oxidase / metabolism*
-
Monoamine Oxidase Inhibitors / chemical synthesis
-
Monoamine Oxidase Inhibitors / chemistry
-
Monoamine Oxidase Inhibitors / pharmacology*
-
Selegiline / pharmacology
-
Structure-Activity Relationship
Substances
-
Benzylamines
-
Chromones
-
Coumarins
-
Indans
-
Ligands
-
Monoamine Oxidase Inhibitors
-
N-(3-chlorophenyl)-6-methylchromone-3-carboxamide
-
N-(3-chlorophenyl)-6-methylcoumarin-3-carboxamide
-
rasagiline
-
Selegiline
-
safinamide
-
Monoamine Oxidase
-
monoamine oxidase A, human
-
Clorgyline
-
Alanine